DESMOND HELLMANN SUSAN D 4
4 · GENENTECH INC · Filed Mar 30, 2009
Insider Transaction Report
Form 4
DESMOND HELLMANN SUSAN D
PRESIDENT,
Transactions
- Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2009-03-26−360,000→ 0 totalExercise: $53.23From: 2004-09-23Exp: 2014-09-23→ Common Stock (360,000 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2009-03-26−360,000→ 0 totalExercise: $42.05From: 2003-09-11Exp: 2013-09-11→ Common Stock (360,000 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2009-03-26−240,000→ 0 totalExercise: $79.17From: 2007-09-20Exp: 2016-09-20→ Common Stock (240,000 underlying) - Disposition to Issuer
Common Stock
2009-03-26$95.00/sh−1,639$155,705→ 0 total - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2009-03-26−175,000→ 0 totalExercise: $20.90From: 2001-09-26Exp: 2011-09-26→ Common Stock (175,000 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2009-03-26−362,808→ 0 totalExercise: $40.99From: 2000-09-20Exp: 2010-09-20→ Common Stock (362,808 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2009-03-26−300,000→ 0 totalExercise: $85.83From: 2005-09-23Exp: 2015-09-23→ Common Stock (300,000 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2009-03-26−210,000→ 0 totalExercise: $79.55From: 2008-09-20Exp: 2017-09-20→ Common Stock (210,000 underlying)
Footnotes (4)
- [F1]Disposed of pursuant to the Agreement and Plan of Merger between the issuer, Roche Holdings Inc. and Roche Investments USA dated March 12, 2009.
- [F2]At the effective time of the merger, this option vested in full and was cancelled in exchange for a cash amount equal to the net value of the exercise price and the merger consideration.
- [F3]At the effective time of the merger, this option vested in full and was cancelled in exchange for a cash amount equal to the net value of the exercise price and the merger consideration.
- [F4]At the effective time of the merger, this option vested in full and was cancelled in exchange for a cash amount equal to the net value of the exercise price and the merger consideration.